ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
22.3775
-0.145
(-0.64%)
Cerrado 12 Enero 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
22.3775
Postura de Compra
22.345
Postura de Venta
22.41
Volume Operado de la Acción
2,000
22.16 Rango del Día 22.16
0.00 Rango de 52 semanas 0.00
Precio Anterior
22.5225
Precio de Apertura
22.16
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
US$ 44,320
Precio Promedio Ponderado
22.16

BTCW Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CrimsonNightRider CrimsonNightRider 2 minutos hace
Sad
ASTA
CrimsonNightRider CrimsonNightRider 5 minutos hace
Low
Budget
Turd
EDXC
willyw willyw 14 minutos hace
I nearly posted this a week ago and just decided to let it slide, I was DX'ed in 2003 w/ HCV and at that time there were estimated to be about 3.1 mil.
One has to remember an estimate is all we'll ever have, it's a part fact on solid stats and some is a projection.
Gilead and Abbvie ha
SDCRBS SDCRBS 16 minutos hace
We have been through several fires (in Southern California) and in our closest (2004) we evacuated and the homes around burnt to the ground, but ours was spared. The fire we were in before that one was one for the record books. The Fire Chief told me that when that fire jumped a main highway, (it wa
GDVM
Pickme2 Pickme2 18 minutos hace
Typical comment by a manipulator trying to pump and dump... don't get Condogged by a 🤡
ATMH
Guido2 Guido2 19 minutos hace
https://x.com/guidoperei/status/1878327550721544357?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
leavetheguntakethecannolis leavetheguntakethecannolis 28 minutos hace
4 days does seem like a long time to wait for a response. Especially when it's the same poster.
IPIX
leavetheguntakethecannolis leavetheguntakethecannolis 30 minutos hace
4 million does not equal 1.4 million and 1.4 million does not equal 4 million. Only in agenda driven mathematics is this the case.
IPIX
ORCA ORCA 32 minutos hace
BRO 1 MILLION SHARES DID DAMAGE??LMAO.IS THE CD THAT HATES TO SEE ANY SELLER.
AXXA
Don Faton Don Faton 32 minutos hace
Email got hacked unfortunately my twitter page has the new one.   Thanks PB 
SRNW
Don Faton Don Faton 34 minutos hace
Can we be all friends.  

I would like to know when sharp will tweet again and pull his head out of his ass. 

When we getting the supposed name and ticker change.  Nothing like the stock price bleeding down. As usual.  So frustrating 
WNFT
EmpressMonk25 EmpressMonk25 37 minutos hace
If you did your homework, it was clear the company had impressive products; the fault in progress was with Gensler, and the price was actually rock bottom.

Perhaps you were not paying attention, or maybe the accusations of Foote being a criminal and claims of this being the greatest s
HMBL
jimr1717 jimr1717 38 minutos hace
🏆️ Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analytic, Inc.
30,000,000 Share
ATMH
jondoeuk jondoeuk 38 minutos hace
KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
NVCR
Golden Cross Golden Cross 38 minutos hace
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Golden Cross Golden Cross 40 minutos hace
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Kool Aid Man Kool Aid Man 40 minutos hace
I can't wait for the PR explaining the need for 700 million more shares. Never ending source of entertainment
SPZI
dstock07734 dstock07734 41 minutos hace
Gary,

I strongly suggest you go through the details of all the outcome measures adopted in the combo trial. They are so disruptive. I also think we should abandon the old concept about the definition of phase on clinical trials. The phase definition for DCVax-L doesn't matter. What it
NWBO
manibiotech manibiotech 41 minutos hace
Yep you did get it straight .
There is a reason companies apply to FDA and EMA . And there is reason for current SP.
But problem is that when given  straight to you , you can't comprehend straightforward reasons 
NWBO
Lime Time Lime Time 42 minutos hace
Very good opportunity
GVSI
gshores gshores 46 minutos hace
Nothing personal, but you reek of desperation for some reason. Longs will do great here.
SPZI
jondoeuk jondoeuk 47 minutos hace
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
NVCR

Su Consulta Reciente

Delayed Upgrade Clock